Objectives To introduce healthcare or biomedical blockchain applications and their
underlying blockchain platforms, compare popular blockchain platforms using a systematic …

Blockchains are a new approach to creating distributed networks that were first introduced in
2008. It allows the formation of peer-to-peer networks based on consensus, forming chains …

Counterfeit drugs are one of the most severe threats to the pharmaceutical industry. World
Health Organization (WHO) highlights that nearly 1035% of the drugs, ie, one out of ten …

A PubMed query run in June 2018 using the keyword 'blockchain'retrieved 40 indexed
papers, a reflection of the growing interest in blockchain among the medical and healthcare …

Background Blockchain has the potential to disrupt the current modes of patient data access,
accumulation, contribution, exchange, and control. Using interoperability standards, smart …

Monitoring and ensuring the integrity of data within the clinical trial process is currently not
always feasible with the current research system. We propose a blockchain-based system to …

To solve the problems of high latency, high system overhead, and small supported scale in
the current application of pharmaceutical traceability combined with blockchain technology …

Blockchain is a shared distributed digital ledger technology that can better facilitate data
management, provenance and security, and has the potential to transform healthcare …

Abstract Background Clinical Trials (CTs) help in testing and validating the safety and
efficacy of newly discovered drugs on specific patient population cohorts. However, these …

Dynamic consent aims to empower research partners and facilitate active participation in the
research process. Used within the context of biobanking, it gives individuals access to …